BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO., LTD. Financials Beijing Chunlizhengda Medical Instruments Co., Ltd.
Equities
1858
CNE100001TP1
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.6 HKD | +0.52% |
|
+9.43% | -6.90% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,668 | 6,375 | 9,084 | 8,198 | 8,673 | 7,597 | - | - |
| Enterprise Value (EV) 1 | 5,204 | 5,685 | 7,349 | 7,241 | 8,673 | 7,597 | 7,597 | 7,597 |
| P/E ratio | 24 x | 22.5 x | 13.3 x | 17.6 x | 15.7 x | 11.9 x | 9.36 x | 7.36 x |
| Yield | 0.18% | - | - | - | - | - | - | - |
| Capitalization / Revenue | 6.63 x | 6.8 x | 8.2 x | 6.82 x | 7.18 x | 5.07 x | 3.99 x | 3.18 x |
| EV / Revenue | 6.63 x | 6.8 x | 8.2 x | 6.82 x | 7.18 x | 5.07 x | 3.99 x | 3.18 x |
| EV / EBITDA | 20.3 x | 18.5 x | 23.6 x | 23 x | 25.6 x | 20 x | 15.7 x | 12.4 x |
| EV / FCF | 57.2 x | - | - | - | 18.1 x | 66.6 x | 23.2 x | 16.3 x |
| FCF Yield | 1.75% | - | - | - | 5.52% | 1.5% | 4.3% | 6.13% |
| Price to Book | 7.03 x | 5.91 x | 1.92 x | 1.99 x | 1.51 x | 1.27 x | 1.12 x | 0.97 x |
| Nbr of stocks (in thousands) | 345,852 | 345,852 | 384,280 | 383,569 | 383,569 | 383,568 | - | - |
| Reference price 2 | 16.39 | 18.43 | 12.34 | 14.10 | 11.32 | 10.67 | 10.67 | 10.67 |
| Announcement Date | 3/16/20 | 3/29/21 | 2/24/22 | 2/27/23 | 2/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 855.3 | 937.7 | 1,108 | 1,202 | 1,209 | 1,498 | 1,904 | 2,390 |
| EBITDA 1 | 279.9 | 345.3 | 384.4 | 357.2 | 339.2 | 380.1 | 484 | 613.9 |
| EBIT 1 | 273.5 | 330.1 | 367.6 | - | 306 | 369.2 | 471.7 | 598.2 |
| Operating Margin | 31.98% | 35.2% | 33.17% | - | 25.32% | 24.63% | 24.77% | 25.04% |
| Earnings before Tax (EBT) 1 | 273 | 329.8 | 367.4 | 336.9 | 305.9 | 368.7 | 471.2 | 598.2 |
| Net income 1 | 236.8 | 283.4 | 322.4 | 307.7 | 277.8 | 334.7 | 427.5 | 542.1 |
| Net margin | 27.68% | 30.22% | 29.09% | 25.61% | 22.99% | 22.34% | 22.45% | 22.69% |
| EPS 2 | 0.6840 | 0.8200 | 0.9300 | 0.8000 | 0.7200 | 0.9000 | 1.140 | 1.450 |
| Free Cash Flow 1 | 99.13 | - | - | - | 478.5 | 114 | 327 | 466 |
| FCF margin | 11.59% | - | - | - | 39.59% | 7.61% | 17.17% | 19.5% |
| FCF Conversion (EBITDA) | 35.41% | - | - | - | 141.05% | 29.99% | 67.57% | 75.91% |
| FCF Conversion (Net income) | 41.87% | - | - | - | 172.22% | 34.06% | 76.49% | 85.96% |
| Dividend per Share | 0.0300 | - | - | - | - | - | - | - |
| Announcement Date | 3/16/20 | 3/29/21 | 2/24/22 | 2/27/23 | 2/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 S1 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income | - |
| Net margin | - |
| EPS 1 | 0.3300 |
| Dividend per Share | - |
| Announcement Date | 8/30/23 |
1CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | 464 | 690 | 1,735 | 957 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 99.1 | - | - | - | 478 | 114 | 327 | 466 |
| ROE (net income / shareholders' equity) | 33% | 30.1% | 18.2% | 11.9% | 9.93% | 10.7% | 12.3% | 13.9% |
| ROA (Net income/ Total Assets) | 23.4% | 20.6% | 14.2% | 9.6% | 7.61% | 8.39% | 9.28% | 10.1% |
| Assets 1 | 1,012 | 1,378 | 2,271 | 3,205 | 3,650 | 3,989 | 4,607 | 5,357 |
| Book Value Per Share 2 | 2.330 | 3.120 | 6.430 | 7.080 | 7.500 | 8.400 | 9.550 | 11.00 |
| Cash Flow per Share 2 | 1.670 | 0.7500 | 0.5100 | 0.1100 | 1.330 | 0.7000 | 0.7200 | 0.9300 |
| Capex 1 | 132 | 23.9 | 199 | 24.8 | 33.2 | 41.3 | 52 | 54.2 |
| Capex / Sales | 15.48% | 2.55% | 17.99% | 2.07% | 2.75% | 2.75% | 2.73% | 2.27% |
| Announcement Date | 3/16/20 | 3/29/21 | 2/24/22 | 2/27/23 | 2/28/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.67
CNY
Average target price
18.35
CNY
Spread / Average Target
+71.93%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.90% | 1.05B | |
| +13.16% | 129B | |
| -9.23% | 10.77B | |
| +3.60% | 9.05B | |
| +19.75% | 7.38B | |
| +22.28% | 4.88B | |
| +7.55% | 3.41B | |
| -0.21% | 3.07B | |
| -4.80% | 2.24B | |
| -4.72% | 2.12B |
- Stock Market
- Equities
- 1858 Stock
- Financials Beijing Chunlizhengda Medical Instruments Co., Ltd.
